Cargando…
Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) involves sporadic expression of DUX4, which inhibits myogenesis and is pro-apoptotic. To identify target genes, we over-expressed DUX4 in myoblasts and found that the receptor tyrosine kinase Ret was significantly up-regulated, suggesting a role in FSHD....
Autores principales: | Moyle, Louise A, Blanc, Eric, Jaka, Oihane, Prueller, Johanna, Banerji, Christopher RS, Tedesco, Francesco Saverio, Harridge, Stephen DR, Knight, Robert D, Zammit, Peter S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108591/ https://www.ncbi.nlm.nih.gov/pubmed/27841748 http://dx.doi.org/10.7554/eLife.11405 |
Ejemplares similares
-
Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7
por: Banerji, Christopher R S, et al.
Publicado: (2021) -
Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity
por: Banerji, Christopher R S, et al.
Publicado: (2020) -
PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle
por: Banerji, Christopher R. S., et al.
Publicado: (2017) -
The socioeconomic burden of facioscapulohumeral muscular dystrophy
por: Blokhuis, Anna M., et al.
Publicado: (2021) -
The FSHD muscle–blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy
por: Banerji, Christopher R S, et al.
Publicado: (2023)